Showing results (391-400 of 2,126) with videos related to
Sort By:
Pageof 213
Helicobacter|June 1, 2022
Efficacy and safety of low-dose rifabutin-based 7-day triple therapy as a third- or later-line Helicobacter pylori eradication regimenKazumi Inokuchi, Hideki Mori, Juntaro Matsuzaki, et al.Helicobacter|December 20, 2022
Helicobacter pylori-positive chronic atrophic gastritis and cellular senescenceShi-Yu Zheng, Lu Zhu, Lu-Yi Wu, et al.Helicobacter|November 27, 2022
Discussion on the common controversies of Helicobacter pylori infectionHang Yang, Yi Mou, Bing HuHelicobacter|December 2, 2022
Quadruple therapy with vonoprazan 20 mg daily as a first-line treatment for Helicobacter pylori infection: A single-center, open-label, noninferiority, randomized controlled trialLifen Lu, Yujing Wang, Jun Ye, et al.Helicobacter|December 5, 2022
Helicobacter pylori regulated microRNA map of human gastric cellsPoornima Ramesh, Sreeranjini Babu, Shruthi Ammankallu, et al.Helicobacter|June 9, 2022
Influences of Helicobacter pylori infection on diversity, heterogeneity, and composition of human gastric microbiomes across stages of gastric cancer developmentWanmeng Xiao, Zhanshan Sam MaHelicobacter|December 28, 2019
Mucoid and coccoid Helicobacter pylori with fast growth and antibiotic resistanceSara Kadkhodaei, Farideh Siavoshi, Kambiz Akbari NoghabiHelicobacter|October 1, 2020
The relation between Helicobacter pylori immunoglobulin G seropositivity and leukocyte telomere length in US adults from NHANES 1999-2000Jin-Wen Huang, Chuanbo Xie, Zhongzheng Niu, et al.Helicobacter|October 28, 2020
Modified bismuth quadruple therapy with low-dose metronidazole as first-line therapy for Helicobacter pylori infectionGyu Young Pih, Kee Don Choi, Eun Jeong Gong, et al.Helicobacter|January 5, 2021
AI-2 represses CagA expression and bacterial adhesion, attenuating the Helicobacter pylori-induced inflammatory response of gastric epithelial cellsYancheng Wen, Hongming Huang, Tiechen Tang, et al.Pageof 213